These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37508226)

  • 1. Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria.
    Rivera-Villegas HO; Martinez-Guerra BA; Garcia-Couturier R; Xancal-Salvador LF; Esteban-Kenel V; Jaimes-Aquino RA; Mendoza-Rojas M; Cervantes-Sánchez A; Méndez-Ramos S; Alonso-Montoya JE; Munguia-Ramos D; Tamez-Torres KM; Roman-Montes CM; Rajme-Lopez S; Martínez-Gamboa A; Bobadilla-Del-Valle M; Gonzalez-Lara MF; Sifuentes-Osornio J; Ponce-de-Leon A
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
    Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Wu D; Chen C; Liu T; Jia Y; Wan Q; Peng J
    Infect Dis Ther; 2021 Mar; 10(1):559-573. PubMed ID: 33611687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation.
    Liu Y; Liu Y; Liu Y; Chen X; Jia Y
    Heliyon; 2023 Apr; 9(4):e15285. PubMed ID: 37101646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study.
    Zhuang HH; Chen Y; Hu Q; Long WM; Wu XL; Wang Q; Xu TT; Qu Q; Liu YP; Xiao YW; Qu J
    J Infect Public Health; 2023 Jun; 16(6):938-947. PubMed ID: 37087853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases.
    Jian X; Du S; Zhou X; Xu Z; Wang K; Dong X; Hu J; Wang H
    Front Cell Infect Microbiol; 2022; 12():969117. PubMed ID: 36683699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study.
    Abubakar U; Zulkarnain AI; Rodríguez-Baño J; Kamarudin N; Elrggal ME; Elnaem MH; Harun SN
    Trop Med Infect Dis; 2022 Dec; 7(12):. PubMed ID: 36548670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria.
    Wang J; Mu M; Zhu J; Yang J; Tao Y; Chen Y; Hu Q; Zhou H; Zhao A; Niu T
    Ann Hematol; 2024 Oct; 103(10):4021-4031. PubMed ID: 38958702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
    Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission.
    Dai Y; Zhang L; Pan T; Shen Z; Meng T; Wu J; Gu F; Wang X; Tan R; Qu H
    Antimicrob Resist Infect Control; 2023 Oct; 12(1):118. PubMed ID: 37898771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma.
    Ceccarelli G; Alessandri F; Moretti S; Borsetti A; Maggiorella MT; Fabris S; Russo A; Ruberto F; De Meo D; Ciccozzi M; Mastroianni CM; Venditti M; Pugliese F; d'Ettorre G
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU.
    Yu J; Zuo W; Fan H; Wu J; Qiao L; Yang B; Li W; Yang Y; Zhang B
    Infect Drug Resist; 2023; 16():6209-6216. PubMed ID: 37727274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
    Costa Pde O; Atta EH; Silva AR
    J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study.
    Yang KY; Peng CK; Sheu CC; Lin YC; Chan MC; Wang SH; Chen CM; Chen CY; Zheng ZR; Feng JY;
    J Intensive Care; 2023 Jan; 11(1):1. PubMed ID: 36597165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study.
    Zhang X; Qi S; Duan X; Han B; Zhang S; Liu S; Wang H; Zhang H; Sun T
    J Transl Med; 2021 Oct; 19(1):431. PubMed ID: 34656132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients.
    Wu Q; Qian C; Yin H; Liu F; Wu Y; Li W; Xia L; Ma L; Hong M
    Front Oncol; 2022; 12():897479. PubMed ID: 35651791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.